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RETROMOLAR SMALL CELL NEUROENDOCRINE 
CARCINOMA: CASE REPORT
P. Radulović1, Z. Marušić1, I. Pavić1, L. Kalogjera2,
D. Tomas1
1Ljudevit Jurak University Department of Pathology,
2University Department of ENT, Head and Neck Surgery, 
Sestre milosrdnice University Hospital, Zagreb, Croatia
Small cell carcinoma (SmCC) is a poorly diff er-
entiated neuroendocrine carcinoma that has been 
reported in several sites throughout the head and 
neck region, including salivary glands where it is a 
rare primary tumor accounting for less than 1% of all 
salivary gland tumors. We report a case of a 55-year-
old man with problems consisting of neck pain and 
diffi  cult swallowing induced by a retromolar mass. 
Physical examination revealed an exophytic infi ltra-
tive process in the right retromolar trigonum, mea-
suring 2 centimeters in diameter. On cut surface the 
tumor was white and grayish. Microscopically, it was 
composed of sheets, ribbons and nests of mitotically 
active tumor cells set within a variably fi brous stroma. 
Th ere was a positive immunohistochemical reaction 
for broad spectrum keratin, EMA, synaptophysin and 
chromogranin. Th e combination of fi ndings was in 
favor of small cell neuroendocrine carcinoma with 
the probable origin from a small salivary gland. In 
the 2005 WHO classifi cation of head and neck tu-
mors, SmCC of salivary glands is defi ned as a rare 
malignant epithelial tumor. Diff erential diagnosis 
includes metastatic pulmonary SmCC and cutaneous 
neuroendocrine carcinoma (Merkel cell carcinoma). 
Although salivary gland SmCC does not metastasize 
as frequently as pulmonary SmCC, locoregional me-
tastases are present at diagnosis in as many as 50% of 
cases. SmCC arising in major or minor salivary glands 
has a better prognosis than pulmonary SmCC, but in 
our case the patient survived for just one month after 
the diagnosis. Th e autopsy confi rmed oropharynx as 
the primary location of the tumor. Besides multiple 
liver metastases, there were no signs of tumor any-
where else in the body.
MELANOMA METASTASIS TO THYROID
FOLLICULAR ADENOMA
A. Pačić1, I. Pavić2, N. Mateša3, M. Škerlj4,
L. Pažanin2
1Department of Pathology, Dubrava University Hospital; 
2Ljudevit Jurak University Department of Pathology;
3Department of Nuclear Medicine, Sestre milosrdnice
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Clinically signifi cant metastases to thyroid gland 
are very rare. Th e incidence of thyroid involvement by 
metastatic disease ranges from an average of 3.1% in 
surgical series to 5.3% in autopsy series. Metastases to 
pre-existing thyroid neoplasms are distinctly uncom-
mon. Malignant melanoma is one of the tumors that 
may metastasize to thyroid gland. We describe a case 
of a woman with thyroid metastases from a nodular 
melanoma discovered by fi ne-needle aspiration biopsy 
of thyroid nodule. Six months before, a 67-year-old 
woman was diagnosed with malignant nodular mela-
noma on the right upper arm. Axillary lymph nodes 
were positive. Follow-up examination revealed nodu-
lar enlargement of the right thyroid lobe. Fine-needle 
aspiration (FNA) showed the presence of epitheloid 
cells with nuclear atypia and cytoplasmic pigmenta-
tion. Morphological features suggested thyroid me-
tastasis from malignant melanoma and thyroidectomy 
was performed. Pathologic examination revealed a 
completely encapsulated nodule measuring up to 1 cm 
in diameter, showing histopathologic features of folli-
cular adenoma with no evidence of capsular or vascular 
invasion. Th e adenoma was infi ltrated by a nodule of 
immunohistochemically HMB45 positive malignant 
cells containing dark pigment. Th e incidental meta-
static nodule was found in the opposite thyroid lobe. 
Th yroid nodule in patients with a history of malig-
nancy can be a benign lesion, new primary carcinoma 
or distant metastasis. Our case supports the argument 
that any patient with a thyroid mass and a history of 
malignancy should be considered to have a metastasis 
until proven otherwise. FNA has an important role 
in diff erentiation of benign, malignant and probably 
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malignant cell cells in thyroid gland. However, due to 
the possible mimicking metastases that simulate pri-
mary thyroid neoplasm, histopathology examination 
and appropriate use of immunohistochemistry remain 
the gold standard in achieving an accurate diagnosis. 
COEXPRESSION OF 4-HYDROXYNONENAL AND 
PROMININ-1 IN ASTROCYTOMAS
D. Kolenc, K. Žarković
Department of Pathology, School of Medicine, University 
of Zagreb, Zagreb, Croatia
Oxidative stress (OS) is a condition that occurs 
when antioxidative capacity of tissue and cells is over-
come. Th e oxidative damage of cells is caused by free 
radicals which are products of OS. In equilibrium, 
free radicals are disintegrated by enzymatic and non-
enzymatic proteins. Lipid peroxidation is an autocata-
lytic process caused by OS, which damages lipids and 
causes production of highly reactive species such as 
hydroxynonenal (HNE). HNE is thought to be the 
second toxic messenger that damages cells causing 
their death. Reactive oxygen species (ROS) and reac-
tive nitrogen species (RNS) are products of OS and 
they play an important role in both initiation and pro-
motion of carcinogenesis. Th e brain is very vulnerable 
to damage mediated by ROS when cells in the central 
nervous system (CNS) have low levels of antioxidant 
defenses, high iron content and high level of poly-un-
saturated fatty acids. Th e cancer stem cell hypothesis 
suggests that not all cells in the tumor have the same 
ability to proliferate and maintain the growth of the 
tumor. Only a relatively small fraction of cells in the 
tumor, termed cancer stem cells, possess the ability 
to proliferate and self-renew extensively. Prominin-1 
(CD133) has been identifi ed in both human and mice, 
and was originally classifi ed as a marker of primitive 
hematopoietic and neural stem cells. Diff erent tis-
sue damages to CNS, such as trauma, viruses and 
ischemia, increase the amount of OS product which 
damages the endothelial cells, which consequently 
increase production from bone marrow-derived en-
dothelial progenitor cells (EPCs). EPCs are immuno-
reactive for CD133 and CD34 and thus important in 
the process of angiogenesis. Th e aim of this study was 
to determine the coexpression of HNE-histidine con-
jugates and CD133 in astrocytomas. Th e expression 
of HNE in 30 diff use astrocytomas (DA), 30 anaplas-
tic astrocytomas (AA), and 30 glioblastomas (GBM) 
was analyzed using monoclonal antibody on HNE-
histidine conjugates and polyclonal antibody on pro-
minin-1 (CD133). HNE immunopositivity was found 
in all astrocytomas and the intensity was proportional 
to astrocytoma malignancy. Th e weakest presence of 
HNE was found in DA, followed by AA and GBM. 
Th e remarkable immunopositivity for HNE was found 
in tumor cells, stroma and blood vessels in malignant 
variants of astrocytomas (AA and GBM). CD133 was 
found in all astrocytomas and the intensity was also 
proportional to astrocytoma malignancy. Th e remark-
able immunopositivity for CD133 was found in tumor 
cells and stroma in AA and GBM. Th e coexpression 
of HNE and CD133 was signifi cant in tumor cells 
and stroma of AA and GBM compared to DA. Th e 
increase in HNE and CD133 immunoreactivity in 
tumor cells, blood vessels and stroma in astrocytomas 
with an increase in their malignancy indicates that 
both markers could be good prognostic indicators.
NEUROENDOCRINE CANCER OF THE BREAST: 
A REPORT OF 11 CASES
M. Perić-Balja1, S. Ramić1, T. Bujas2, F. Knežević1
1Department of Pathology, University Hospital for Tumors, 
Zagreb;
2Department of Pathology, Karlovac General Hospital, 
Karlovac, Croatia
Neuroendocrine cancer (NC) of the breast is rare, 
usually showing alveolar structures or solid sheets of 
cells with a tendency to produce peripheral palisading. 
Th e expression of neuroendocrine markers chromogr-
anin and/or synaptophysin in more than 50% of the 
cell population confi rms neuroendocrine diff erentia-
tion. Depending upon the cell types, grade and de-
gree of diff erentiation, NC has been categorized into 
the following subtypes: solid, small cell and large cell 
NC. All 11 patients were aged from 48 to 86 (median 
57) years. Th e tumor size median was 17 mm (10-48 
mm) in diameter. Eight tumors were classifi ed as sol-
id, two as small cell and one as large cell type. Immu-
nohistochemical examination was carried out using 
the following antibodies: chromogranin A, synapto-
physin, estrogen receptor (ER), progesterone recep-
tor (PR), androgen receptor (AR), human epidermal 
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growth factor receptor-2 (HER-2) and Ki67. Positive 
reactivity for chromogranin A (8/11) and synapto-
physin (11/11) confi rmed neuroendocrine diff erentia-
tion in 11 cases of breast cancer. Immunohistochemi-
cally, the tumors expressed ER (11/11), PR (8/11) and 
AR (10/11), while HER-2 was negative in all cases. 
Median value for Ki-67 was 18% (range 7%-55%) and 
for the number of mitoses 4 (range 3-31). In one-way 
analysis of variance, histologic grade was infl uenced 
by the number of mitoses (P=0.0096) and tumor size 
(P=0.0035). Axillary lymph nodes were positive in 
two patients (2/11). Disease recurrence with distant 
metastases occurred, after 20 months, only in the pa-
tient with large cell subtype. All other patients were 
free of disease at the time of writing. Median follow-
up was 20.5 (range 11-45) months. NC of the breast 
frequently expresses ER, PR and AR, while HER-2 is 
negative. Histologic subtype, grade and size of tumor 
are very important prognostic factors. More cases and 
longer follow-up periods are required to determine 
the behavior of these tumors.
PROPOSAL OF CLAUDIN-LOW BREAST 
CARCINOMA MODEL TO UNDERSTAND ITS 
AGGRESSIVE BIOLOGICAL PROPERTIES
A.M. Szasz1, C.S. Jakab1,2, F. Szekely2, B. Szekely1,3, 
M. Dank3, G. Szentmartoni3, Z. Baranyai4,
L. Madaras1, A. Kiss1, A.M. Tokes1, J. Kulka1
12nd Department of Pathology, Semmelweis University; 
2Szent Istvan University, Faculty of Veterinary Medicine, 
Department of Pathology and Forensic Veterinary 
Medicine; 
3Department of Diagnostic Radiology and Oncotherapy, 
Semmelweis University;
4Department of Surgery and Vascular Surgery, Uzsoki 
Memorial Hospital, Budapest, Hungary
Th e claudin-low subclass has emerged relatively 
recently as a further subtype of triple negative breast 
carcinomas. Although it has a very low incidence, 
understanding its behavior is crucial for its poor 
prognostic properties and therapeutic importance. 
Claudin-3, -4, -7 and E-cadherin are able to separate 
the claudin-low subtype of tumors with reasonable 
confi dence both at RNA and protein level. An elevated 
expression of claudin-4 has been described in basal-
like breast cancer, and further characterization of this 
subgroup has led to the identifi cation of claudin-low 
carcinomas with low claudin-4 expression. Due to 
their rarity, claudin-low breast carcinomas pose a great 
challenge for the breast cancer research community. As 
human triple negative carcinomas bear myoepithelial 
properties and claudin-low tumors are considered to 
originate from their progenitors, the stem cells, we 
undertook a hypothesis driven approach to propose 
a claudin-4 low expression model of canine breast 
cancers for human claudin-low tumors as 1) mamma-
ry cancer is the most common type of cancer in female 
dogs and with a lifetime risk of over 24% when dogs 
are not spayed; 2) these carcinomas frequently show 
an aggressive phenotype with 3) their cells displaying 
myoepithelial features. We were able to confi rm the 
raising based on the following: histologic appearance 
(in order to fi nd the common and the divergent 
features) and claudin-4 expression in metastasizing 
carcinomas of dogs compared to human triple negative 
breast carcinomas; identifi cation of the claudin-low 
group of cancers amongst dog’s and human triple 
negative breast carcinomas; and comparison of the 
biological behavior of the claudin-low tumors in the 
two species.
VERMINOUS PNEUMONIA IN CALIFORNIA SEA 
LIONS: CORRELATION BETWEEN GROSS AND 
HISTOPATHOLOGIC LESIONS
M. Pavić1, A. Petak1, S. Tkalčić2
1Faculty of Veterinary Medicine, University of Zagreb, 
Croatia;
2College of Veterinary Medicine, Western University of 
Health Sciences, Pomona, CA, USA
Respiratory tract nematodes, along with gastroin-
testinal (GI) tract nematodes, are common fi ndings in 
marine mammals rescued along the California Coast. 
Most of the parasites commonly found are metazoans: 
small and large roundworms (Otostrongylus circumli-
tus, Anisakis sp., Parafi laroides decorus). Th e animals 
typically present with severe weight loss, weakness, 
anorexia, and respiratory distress, in addition to dark 
diarrhea associated with GI parasitism. Pinnipeds are 
either primary, intermediate or transport hosts for 
many parasites in the marine environment, and there-
fore are intimately involved in movement of parasites 
between aquatic birds, fi sh, and other aquatic mam-
mals. In this research, we studied the morphology and 
histopathology of respiratory tract lesions associated 
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with verminous pneumonia in California Sea Lions 
(Zalophus californianus). Tissue specimens were ob-
tained from 30 stranded pinnipeds necropsied at the 
local rehabilitation centers in the period of 3 years. Th e 
lesions were identifi ed, evaluated, and correlated with 
the associated gross pathological fi ndings. Adults and 
larvae of metazoans were found in the pulmonary pa-
renchyma and airways, with a considerable variation 
in the response of the host tissue to the parasite. Th e 
goal of this project is to identify common histopatho-
logic fi ndings of verminous pneumonia in California 
Sea Lions, evaluate the extent of diff erent parameters 
present, and correlate histopathologic lesions with 
gross pathological fi ndings. Th ese results are expected 
to provide a useful reference for gross morphological 
and histopathologic evaluation of lesions associated 
with respiratory parasites in pinnipeds at necropsy.
PRIMARY THYROID LYMPHOMAS: MOST
COMMON SUBTYPES OF NON HODGKIN’S
LYMPHOMA
E. Lovrić, A. Škrtić, M. Dominis
Department of Pathology and Cytology, Merkur University 
Hospital, Zagreb, Croatia
Primary lymphoma in the thyroid gland (PTL) 
is a relatively rare disease. Elderly individuals and 
females are mostly aff ected. Defi nitive diagnosis of 
primary thyroid extranodal lymphoma can only be 
established by exclusion of extranodal progression 
of any subtype of primary nodal lymphoma. Diff use 
large B-cell lymphoma (DLBCL) and extranodal 
marginal zone B-cell lymphoma of mucosa-associated 
lymphoid tissue (MALT lymphoma) are the most 
common subtypes in thyroid gland. Th e aims of this 
review were to evaluate the spectrum of PTLs using 
the WHO classifi cation schemes (2008) and immu-
nohistochemical markers in our institution. Th e ma-
jority of cases (n=7) were received as consultations 
from 2003 to 2009 and clinical data were unavail-
able. Th ere were seven women and one men, mean 
age at diagnosis 79.8 years. PTLs were classifi ed as 
MALT lymphoma (n=1), DLBCL (n=6), and folli-
cular lymphoma grade 3 (n=1). Immunohistochemi-
cal staining was performed using diagnostic panel of 
primary antibodies (CD20, CD79a, CD3, CD23, 
CD43, CD10, CD5, CD23, CD43, BCL6, BCL10, 
BCL2, thyroglobulin). Th e tumor most commonly 
presented as diff usely enlarged, rubbery fi rm thyroid 
gland. When forming mass, the tumor ranged in size 
from 1 to 19.5 cm. In our cases, morphology charac-
teristics were those of DLBCL, MALT and follicular 
lymphoma, respectively. Th e cases of DLBCL showed 
immunohistochemically positive results for CD20, 
CD79a and negative for CD3, CD23, CD43, CD10. 
Th e case of MALT lymphoma was positive for CD20, 
while CD5, CD23, CD43 were negative. Th e case of 
follicular lymphoma was positive for CD20, CD10, 
BCL6, BCL2 and negative for CD3. In this small se-
ries and in the published literature, a striking female 
predominance for PTL was noted. Histologically, it 
can be very diffi  cult to distinguish PTL from ana-
plastic thyroid carcinoma as well as Hashimoto’s thy-
roiditis due to their similar appearance. Th e study by 
Smedby et al. showed an increased risk of non Hodg-
kin’s lymphoma (NHL) in patients with autoimmune 
disorders such as Sjögren’s syndrome, systemic lupus 
erythematosus, autoimmune hemolytic anemia, and 
celiac disease. Th ese results may be based on the com-
mon mechanisms of lymphomagenesis for NHL and 
autoimmune disorders. Future eff orts should involve 
chronic antigenic stimulation (especially in thyroid 
gland) and lymphoid malignancy including molecular 
studies of the population in our country. It may help 
defi ne the underlying biological mechanisms and give 
important clues to lymphomagenesis.
EXPRESSION OF TUMOR NECROSIS
FACTOR-ALPHA (TNF-A) AND VASCULAR
ENDOTHELIAL GROWTH FACTOR 
(VEGF) IN GASTROENTEROPANCREATIC 
NEUROENDOCRINE TUMORS (GEP-NETS) 
AND THEIR CORRELATION WITH TUMOR 
AGGRESSIVENESS
M. Cigrovski-Berković1, M. Ulamec2, P. Radulović2,
T. Čačev3, V. Zjačić-Rotkvić1, B. Krušlin2,
S. Kapitanović3
1Department of Endocrinology, Diabetes and Metabolism; 
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Angiogenesis is a crucial step for tumor growth. 
Vascular endothelial growth factor (VEGF) is a po-
tent endothelial cell mitogen, known to induce vascu-
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lar permeability. Its expression is under the infl uence 
of proinfl ammatory cytokines, mainly tumor necrosis 
factor-alpha (TNF-α). Recent clinical data have proved 
the correlation between microvessel density and tu-
mor progression with VEGF expression in tumor tis-
sue. As gastroenteropancreatic neuroendocrine tu-
mors (GEP-NETs) are highly vascularized neoplasms 
with still unknown etiopathogenesis, we investigated 
the expression of proinfl ammatory cytokine TNF-α 
and VEGF in 48 GEP-NET tissues, and correlated 
it with the expression of Ki67. Surgical and biopsy 
specimens from 46 gastrointestinal neuroendocrine 
tumors (GI-NETs) and 2 pancreatic neuroendocrine 
tumors (PETs) were examined for TNF-α and VEGF 
expression by immunohistochemistry. Of GI-NETs 15 
were of foregut (14 gastric and 1 duodenal) and 31 of 
midgut origin (12 small intestine, 12 appendix and 7 
colon). Among tumors, overall 21 had high prolifera-
tive index (>2% Ki67 positive tumor cells) and 27 (in-
cluding 2 PETs) had low proliferative activity. Immu-
nostaining was graded as follows: 0 no positive cells; 
1 ≤25% positive GEP-NET cells; 2 >25%-50% posi-
tive GEP-NET cells; and 3 ≥50% positive GEP-NET 
cells. Spearman test was used on correlation of TNF-α 
and VEGF with Ki67. Results were considered signifi -
cant at P<0.05. Weakly positive TNF-α staining was 
detected in one PET, 4 foregut and 12 midgut tumors, 
while stronger TNF-α expression (2 and 3) existed in 1 
foregut and 17 midgut tumors. Overall 13 tumors were 
negative for TNF-α. Strong cytoplasmic VEGF im-
munostaining was detected in 30 midgut and 5 foregut 
GI-NETs and both PETs, while 5 GI-NETs of foregut 
origin completely lacked VEGF expression. When 
TNF-α and VEGF expression was correlated with 
Ki67, there was a statistically signifi cant correlation 
between TNF-α and Ki67 (P=0.03), and a tendency 
to statistically signifi cant correlation between VEGF 
and Ki67 (P=0.09). Our study has demonstrated that 
neuroendocrine cells are a major source of TNF-α and 
VEGF, particularly in midgut GI-NETs. This fi nding 
suggests that the mentioned cytokines/growth factor 
are needed to maintain the differentiated state of cap-
illary vessels in these highly vascularized tumors but 
also, as there was a correlation between the TNF-α 
and VEGF expression and tumor proliferative activ-
ity, that they are important for tumor progression.
LARGE CELL NEUROENDOCRINE CARCINOMA 
OF THE COLON AND RECTUM: A REPORT OF 7 
CASES
R. Limani1, L. Gashi Luci1, M. Frančina2, D. Baličević3, 
A. Mijić4, Z. Jukić2, B. Krušlin3, D. Tomas3
1Institute of Pathology, Faculty of Medicine, University 
Clinical Center of Kosovo, Prishtina, Kosovo; 2Nova 
Gradiška General Hospital, Nova Gradiška; 3Ljudevit 
Jurak University Department of Pathology, 4University 
Department of Surgery, Sestre milosrdnice University 
Hospital, Zagreb, Croatia
Neuroendocrine tumors encompass a wide range of 
pathologic entities that display distinct biologic behav-
iors. Large cell neuroendocrine carcinoma (LCNEC) 
is a highly aggressive neoplasm with a very low fre-
quency in the gastrointestinal tract, usually resulting 
in unfavorable outcome. We present a series of seven 
patients diagnosed with LCNEC of the colon and 
rectum in the time period between 2005 and 2010 at 
Ljudevit Jurak University Department of Pathology, 
Sestre milosrdnice University Hospital. Th e average 
patient age was 64 (range, 34-94) years. Th ere were 
fi ve female and two male patients. Th e mean tumor 
size was 7.8 (range, 2-15) cm. Five tumors were located 
in the colon (1 ascending, 1 transverse, 2 descending 
and 1 sigmoid), 1 in cecum and 1 in rectum. Grossly, 
tumors were of endophytic/ulcerative, annular and 
polypoid appearance. Histologically, the tumors were 
composed of large cells of organoid, nesting, trabecu-
lar, rosette-like and palisading pattern and had a high 
mitotic rate. All seven tumors stained positive for im-
munohistochemical neuroendocrine markers, includ-
ing chromogranin (4/7), synaptophysin (5/7), and/or 
neuron specifi c enolase (6/7). Tumors were advanced 
at the time of diagnosis: stage II (n=1), stage III (n=4) 
and stage IV (n=2). We present cases for being rare 
and to emphasize the need of increased awareness of 
the condition as one of the poorest prognostic sub-
groups among primary colorectal tumors.
STEREOLOGY OF THE RAT PLACENTA IN THE 
LAST TRIMESTER OF GESTATION
N. Vrsaljko1, I. Žunić1, Lj. Šerman1, Đ. Grbeša2
1Department of Biology, 
2Department of Histology and Embryology, School of 
Medicine, Zagreb, Croatia
Because of the numerous roles of the placenta in 
fetal period, it is important to understand its devel-
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opment and structure, and due to similarities with 
human placenta, rat is an appropriate experimental 
model. Animals were sacrifi ced on 16th or 19th day 
of gestation. Th e uterus was removed, the placentas 
were isolated, fi xed in 10% formalin and a complete 
series of histologic sections of 10-μm thickness was 
made. Th irty fi ve rat placentas were collected, 21 in 
the experimental group of 16th and 14 in the experi-
mental group of 19th day of gestation. Th ree randomly 
selected placentas from each group were stereological-
ly analyzed. Absolute volumes of placentas and their 
compartments (labyrinth, basal portion and decidua) 
were estimated. Using volume density, we calculated 
the share of glycogen cells and trophoblast giant cells 
(TGC) in the basal part of the placenta. Th e average 
absolute volume of the placenta on 16th day of ges-
tation was 0.064 cm3, from which a labyrinth made 
0.027 cm3, basal part 0.027 cm3, and decidua 0.009 
cm3.  Th e average absolute volume of the placenta on 
19th day of gestation was 0.163 cm3, of which the laby-
rinth made 0.0923 cm3, basal part 0.059 cm3 and de-
cidua 0.011 cm3. In the 16th day of gestation, volume 
density of TGC in the basal layer was higher (0.174) 
in comparisson with 19th day of gestation (0.107). Th e 
volume density of glycogenic cells was 0.379 on the 
16th day and 0.236 on the 19th day of gestation. In con-
clusion, the absolute volume of the whole placenta on 
19th day of gestation signifi cantly increased, as well as 
the share of the labyrinth as the most important part. 
Th e volume densities of glycogenic and giant tropho-
blast cells were higher on the 16th day of gestation 
compared to the 19th day, because the 19th day marks 
the time when the trophoblast invasion is fi nished and 
the defi nitive placenta is formed.
CHOLESTASIS AS THE INITIAL PRESENTATION 
OF ILLNESS IN A FEMALE PATIENT – 
DIFFERENTIAL DIAGNOSIS IN LIVER BIOPSY 
I. Pavić1, Z. Marušić1, A. Bišćanin2, D. Baličević1
1Ljudevit Jurak University Department of Pathology, 
2University Department of Medicine, Sestre milosrdnice 
University Hospital, Zagreb, Croatia
Th e aim is to underline the importance of bilirubin 
laboratory fi ndings in the interpretation of liver biopsy 
performed for the evaluation of cholestatic jaundice. 
We report on retrospective study of repeat liver and 
colon biopsies in a 24-year-old female patient with 
cholestasis. Twelve years before, the patient was diag-
nosed with autoimmune hepatitis and hyperbilirubine-
mia associated with ulcerative colitis that presented as 
a dysplasia associated lesion or mass (DALM). Genet-
ic analysis showed heterozygous TATA genotype for 
bilirubin uridine diphosphate-glucuronosyltransferase 
(UGT-1A1) detecting Gilbert’s syndrome (GS). Since 
then, the patient has been under continuous therapy 
with immunosuppressive drugs and corticosteroids. 
During the last hospitalization, the course of autoim-
mune hepatitis and ulcerative colitis was reevaluated. 
Both liver biopsy specimens, one performed in 2004 
and the other at the time of present hospitalization 
were cut in three step sections and stained with he-
matoxylin and eosin. Seven additional sections were 
stained; one with a trichrome method, the next four 
with pigment detection methods, and the last two 
were immunohistochemically analyzed for CK7 and 
19. All specimens were scored using the histological 
activity index (HAI) of Ishak et al. In addition, all 
colon biopsy slides were reevaluated to confi rm the 
initial diagnosis of DALM. Revisited colon biopsy 
specimens confi rmed the initial diagnosis of DALM. 
Additional colon biopsy was preformed one month 
before the present liver biopsy. It showed only mild 
lymphocytic infi ltrate and no evidence of DALM. 
Liver biopsy performed in 2004 was scored according 
to the histological activity index of Knodell et al. and 
reevaluated together with the new liver biopsy accord-
ing to Ishak et al. Th ere was no signifi cant diff erence 
in liver biopsy scoring by the two methods mentioned. 
Histology revealed only mild portal chronic infl am-
mation with few piecemeal necroses, occasional lym-
phocytic spillover and only 4 spotty acinar necroses 
along the whole cylinder, which measured up to 2.3 
cm. Portal tracts were slightly enlarged due to mild 
fi brosis. Periportal and intralobar bile ducts showed 
mild periductal fi brosis and in one lobar bile duct 
lymphocytic cholangitis was detected by immunohis-
tochemistry. Predominant histological and immuno-
histochemical fi ndings were periportal proliferation of 
slightly dilated bile ductules with no bile concretions. 
Reported HAI grade was 3, and fi brosis staging score 
1. In conclusion, histological features were consistent 
with chronic hepatitis of minimal necroinfl amma-
tory activity. Mild histological fi ndings in liver biopsy 
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resembling almost normal liver that do not correlate 
with cholestatic jaundice require additional attention 
of the pathologist. Potential pitfalls could be bypassed 
with good clinician-pathologist cooperation. First, if 
the hyperbilirubinemia is of the unconjugated type, 
clinicians should think about GS. Failure to consider 
GS as the cause of jaundice may lead to diagnostic 
misinterpretation and, consequentially, inappropriate 
therapy. It is estimated that GS is found in about 5% 
in Caucasians. Although some other conditions can 
present with cholestasis, no additional symptoms in a 
patient with unconjugated hyperbilirubinemia present 
the clue in diff erential diagnosis. Liver biopsy is not a 
helpful tool in the diagnosis of GS.
APOPTOSIS IN TESTICULAR 
TERATOCARCINOMA
T. Džombeta, M. Ulamec, B. Krušlin, M. Belicza 
Ljudevit Jurak University Department of Pathology, Sestre 
milosrdnice University Hospital, Zagreb, Croatia
Apoptosis is an active process which occurs in both 
physiological and pathological conditions. It serves to 
eliminate cells that are no longer needed or are po-
tentially harmful. Testicular teratocarcinoma is a very 
interesting tumor because of its two completely dif-
ferent components: mature, diff erentiated tissue and 
carcinomatous, undiff erentiated part. Th e aim of this 
study was to compare the number of apoptotic cells in 
these two components of testicular teratocarcinoma. 
Fifteen paraffi  n blocks with the diagnosis of mixed 
germ cell tumor (containing both components of ma-
ture teratoma and embryonal carcinoma) from the 
Ljudevit Jurak University Department of Pathology 
archive were used in the study. Apoptotic cells were 
counted per 10 high power fi elds (HPF) under light 
microscope. Th e number of apoptotic cells in teratoma 
ranged from 18 to 31 in 10 HPF (mean 24.9/10 HPF) 
and in carcinoma from 30 to 38 in 10 HPF (mean 
35.3/10 HPF). In teratoma, columnar epithelium 
had a mean of 52.6 apoptotic cells/10 HPF, stratifi ed 
epithelium 8.7 apoptotic cells/10 HPF and cartilage 
2.6 apoptotic cells/10 HPF. Th is was a pilot study in 
which we detected an increased number of apoptotic 
cells in the component of embryonal carcinoma com-
pared to teratoma. In columnar epithelium of terato-
ma, the number of apoptotic cells was higher than in 
carcinoma, which can be explained by its physiological 
function. Further studies on more samples and com-
parison between p53 expression and apoptotic index 
in diff erent parts of tumor are needed.
PAPILLARY RENAL CELL CARCINOMA WITH 
SMOOTH MUSCLE RICH STROMA: CASE 
REPORT
R. Limani1, L. Gashi Luci1, Z. Marušić2, Z. Gatalica3,
B. Krušlin2
1Institute of Pathology, Faculty of Medicine, University 
Clinical Center of Kosovo, Prishtina, Kosovo;
2Ljudevit Jurak University Department of Pathology, 
Sestre milosrdnice University Hospital, Zagreb, Croatia; 
3Department of Pathology, Creighton University Medical 
Center, Omaha, Nebraska, USA
Papillary renal cell carcinoma (PRCC) is the 
second most common malignant epithelial renal 
neoplasm. PRCCs exhibit a broad morphological 
spectrum; areas containing classic papillary, papillary-
trabecular, and/or papillary-solid patterns of growth 
are seen in virtually all cases. True papillae with a fi -
brovascular core lined by neoplastic epithelial cells are 
the hallmark of the tumor. Merino et al. have recently 
reported a series of 6 unusual renal cell tumors with 
prominent proliferation of smooth muscle and tubu-
lar, cystic and papillary elements. We report a case 
of PRCC composed of smooth muscle rich stroma in 
a 44-year-old man with no prior history of disease. 
Grossly, the tumor measured up to 6 cm in greatest 
diameter, had a moderate consistency, with a gray-
white color and necrosis presenting in up to 30% of 
tumor tissue. It penetrated the capsule and invaded 
the perirenal fat. No lymph nodes were encountered. 
Histologically, the tumor was composed of papillary 
and micropapillary fronds with prominent prolifera-
tion of fi brous tissue and smooth muscle in the tumor 
stroma. Immunohistochemistry revealed positive re-
action of tumor cells for cytokeratin, CK7, vimentin, 
CD10 and RCC, while CK20 was negative. Tumor 
stroma stained strongly positive for SMA. Th ere was 
no VHL mutation. Th e smooth muscle rich stroma in 
a PRCC is a new fi nding; further research is necessary 
to clarify the path ogenesis of this tumor.
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APOPTOSIS IN EXPERIMENTAL MOUSE 
TERATOCARCINOMA
N. Sinčić1, M. Vlahović1, F. Paić1, A. Katušić1,
Lj. Šerman1, M. Belicza2, F. Bulić-Jakuš1
1Department of Biology, School of Medicine;
2 Ljudevit Jurak University Department of Pathology, Sestre 
milosrdnice University Hospital, Zagreb, Croatia
Th e aim of this study was to determine the in-
tensity of apoptosis in experimental teratocarcinoma 
during its development, especially during the period 
of its intensive growth (6th-8th week). Th e 7.5-day-
old C3H embryos were transplanted under the kid-
ney capsule of syngeneic adults. Tumors were iso-
lated and weighted after 2, 4, 5, 6 and 8 weeks. Th e 
other group of animals were treated twice a week for 
4 weeks with the demethylating agent 5-azacytidine 
(5azaC) immediately, at one week, two weeks or four 
weeks after transplantation. Apoptosis was analyzed 
by counting apoptotic cells per 10 microscopic fi elds 
on hematoxylin-eosin slides under X400 magnifi ca-
tion. On statistical analyses, Student’s t-test was used. 
Results showed the apoptotic activity to rise during 
8 weeks of teratocarcinoma development in untreated 
animals. No diff erence was observed in the number 
of apoptotic cells between diff erentiated and undif-
ferentiated tissue compartments. In 6th week of de-
velopment, apoptosis was signifi cantly higher in dif-
ferentiated compartment, whereas in 8th week it was 
higher in undiff erentiated compartment. Apoptosis 
in 5azaC treated tumors seems to have occurred with 
no diff erence during development except for a more 
pronounced apoptosis in diff erentiated compartment 
in 5th week. Apoptosis was signifi cantly lower in tu-
mors treated with 5azaC in 6th and 8th weeks of de-
velopment compared to controls.  It is concluded that 
apoptotic activity rises during teratocarcinoma devel-
opment in untreated animals, with a specifi c shift of 
apoptotic activity in the period of the most intense 
teratocarcinoma growth. Th e demethylating agent 
5azaC slightly suppressed apoptotic activity during 
the most intense teratocarcinoma growth period as 
compared to untreated tumors.
CAROTID BODY PARAGANGLIOMA: TWO CASE 
REPORTS
C. Ardeleanu, D. Terzea, A. Georgescu, M. Stoicea,
F. Cionca, M. Comanescu, F. Vasilescu, F. Andrei,
M. Mihai, A. Visan, S. Enache
National Institute of Pathology, Bucharest, Romania
Paragangliomas of the carotid body are rare tu-
mors (incidence 0.012%) originating from sympa-
thetic fi bers at the carotid bifurcation. Th eir growth is 
slow, becoming symptomatic through local mechani-
cal compression of neighboring vascular and neural 
structures. Th e aim of the current report is to present 
the evaluation, management and fi nal outcome in two 
patients with carotid body tumor. Th e fi rst case was a 
27-year-old woman who presented a cervical tumor 
detected by self-examination. Hormonal status was: 
high serum serotonin (362 ng/mL), normal catheco-
lamines and chromogranin A. MRI revealed a 2-cm 
mass near the left external carotid artery. Immuno-
histochemical examination showed chromogranin 
A and synaptophysin positivity, and a 2%-5% Ki67 
proliferative index. Octreoscan did not identify any 
other localization. After surgery, serum serotonin de-
scended to normal levels in three months. Th e second 
case was a 40-year-old woman who presented with a 
neglected 7-year-old latero-cervical tumor, with pro-
gressive enlargement. Preoperative serum serotonin 
level was two times above normal; cathecolamines and 
chromogranin A were normal. Th e histopathological 
and immunohistochemical examinations revealed a 
paraganglioma of the carotid body with positivity for 
neuron specifi c enolase, chromogranin A in tumoral 
cells, and S100 protein (in numerous dendritic cells); 
Ki67 proliferative index was 5%-10%. Postoperatively, 
serum serotonin persisted at high levels. Under treat-
ment with octreotide LAR 20 mg/month, serotonin 
decreased to normal in 6 months. Surgical excision 
of carotid body tumors is curative. Due to a poten-
tially infi ltrating and disseminating growth, carotid 
body tumors should be regarded as semi-malignant 
and should therefore be indicated for surgery at the 
time of diagnosis.
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NASAL MITES AND ASSOCIATED LESIONS 
IN THE UPPER RESPIRATORY TRACT OF 
CALIFORNIA SEA LIONS (ZALOPHUS 
CALIFORNIANUS)
A. Petak1, M. Pavić1, S. Tkalčić2
1Faculty of Veterinary Medicine, University of Zagreb, 
Zagreb, Croatia;
2College of Veterinary Medicine, Western University of 
Health Sciences, Pomona, CA, USA
Upper respiratory parasites are uncommon fi nd-
ing in marine mammals. Although it is not a com-
mon practice to open and thoroughly examine nasal 
turbinates at the time of routine necropsy, we found 
nasal passages of several California sea lions (Zalophus 
californianus), to contain nasal mites (order Halarach-
nidae) of the genera Orthohalarachne, as reported in 
otarrid seals. Of these, most commonly reported in 
California sea lions are adults and larvae of Ortho-
halarachne attenuata and O. diminuata. Although ac-
companied by a mild nasal discharge, clinical obser-
vations have indicated that this infestation does not 
represent a serious clinical condition for the sea lions. 
However, histopathologic fi ndings associated with a 
heavy parasitic load suggested diff erent. Most com-
mon pathological fi ndings include erosions of the re-
spiratory mucosa surrounding attachment sites of the 
mites and accumulations of cellular debris, edema fl u-
id and infl ammatory cells (predominantly neutrophils 
and eosinophils) in nasal passages, nasopharynx, and 
larynx. In non-eroded areas, the epithelium varies 
from normal to atrophic, disorganized to hyperplas-
tic. Th e histopathologic lesions observed suggest that 
sea lions could present with dyspnea due to blockage 
of upper respiratory passages and spread of adult mites 
and larvae deeper into the airways and lungs. We cal-
culated the density of mites in nasal mucosa and sug-
gest that large scale infestations of Orthohalarachne sp. 
in nasopharyngeal mucosa and spread into the phar-
ynx could signifi cantly aff ect the clinical condition of 
the aff ected animal. Also, the nasal mites could lead 
to lower respiratory diseases, pulmonary emphysema, 
and transmit other pathogens, so they should be con-
sidered of signifi cance to the health and rehabilitation 
eff orts of diseased California sea lions. Examination 
of nasal turbinates should therefore be recommended 
on routine necropsy of marine mammals.
LEYDIG CELLS, TESTIS VOLUME AND 
SPERMATOGENESIS IN PATIENTS WITH NON-
OBSTRUCTIVE AZOOSPERMIA
N. Knežević, V. Kozina, M. Kosović, M. Bernat,
Ž. Kaštelan, D. Ježek
Departments of Urology, of Physics, and of Histology and 
Embryology, School of Medicine, University of Zagreb, 
Zagreb, Croatia
In males, Leydig cells are responsible for more 
than 95% of androgen production. Th e aim of our 
study was: (a) to assess morphological features and 
testosterone production in situ of Leydig cells in in-
fertile patients; and (b) to correlate the above-men-
tioned Leydig cell parameters with testis volume and 
spermatogenesis. In total, 120 testicular biopsies were 
used (12 controls and 108 specimens from patients 
with non-obstructive azoospermia). Th e morphology 
of Leydig cells was assessed by semi-thin and ultra-
thin sections (transmission electron microscopy). 
Testosterone production in situ was visualized by im-
munohistochemistry, followed by morphometric (ste-
reological) analysis. Testicular volume was determined 
by ultrasound and/or orchidometer, and the status of 
spermatogenesis by applying Johnsen’s scoring system. 
Patients with non-obstructive azoospermia exhibited 
statistically signifi cantly lower values of testicular vol-
ume and score. Morphological analysis indicated that 
some Leydig cells displayed an extensive change of 
the nucleus and cytoplasm, whereas the number of 
testosterone-producing cells was signifi cantly lower in 
azoospermia cases. Based on our results, patients with 
azoospermia have signifi cant changes in the morphol-
ogy of Leydig cells and their capacity to produce tes-
tosterone. Some of these patients could be candidates 
for premature andropause.
WARTHIN-LIKE TUMOR VARIANT OF 
PAPILLARY THYROID CARCINOMA: CASE 
REPORT
A. Jakovčević1, M. Macan1, K. Žarković1, M. Bura2 
1University Department of Pathology and Cytology, 
2University Department of ENT, Head and Neck Surgery, 
Zagreb University Hospital Center, Zagreb, Croatia
Papillary carcinoma is the most common form of 
thyroid carcinoma and generally has a more favorable 
prognosis than other carcinoma types. Within the 
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group of papillary carcinomas, several morphologi-
cal variants have been described. We present a case of 
a rare variant of thyroid papillary carcinoma similar 
to Warthin’s tumor of salivary gland. In a 67-year-
old woman with euthyroid goiter and tumor nodule 
in the isthmus, fi ne needle aspiration was suspect of 
papillary carcinoma. Th yroidectomy was performed. 
An irregularly bordered grayish tumor nodule mea-
suring 2 cm in diameter was found in the isthmus. 
Th e surrounding thyroid tissue was normal. Histo-
logically, the tumor was composed of solid areas and 
papillary structures. Th e cells covering the papillae 
often had oncocytic appearance. Nuclei were mono-
morphous, clear and ground glass-like with grooves. 
Th e fi brovascular core of the papillae contained an in-
tense lymphoplasmacytic infl ammatory infi ltrate. All 
these features resembled Warthin’s tumor of salivary 
gland. Within the surrounding thyroid parenchyma 
there was nodular lymphocytic infi ltration with ger-
minal center formation. Th e lymph nodes were free 
from metastases. Two years after surgical therapy the 
patient is disease-free. Th is is a rare variant of thyroid 
papillary carcinoma showing histologic similarities to 
Warthin’s tumor of salivary gland and therefore may 
present a diff erential diagnostic problem. Its clinical 
behavior does not diff er from conventional papillary 
carcinoma.
EPIDEMIOLOGIC AND HISTOPATHOLOGIC 
FEATURES OF THYROID CANCER IN CROATIA
R. Granić1, M. Borić1, T. Jukić1, H. Čupić2,
B. Krušlin2, Z. Kusić1
1University Department of Oncology and Nuclear Medicine, 
2Ljudevit Jurak University Department of Pathology, Sestre 
milosrdnice University Hospital, Zagreb, Croatia
Th yroid cancer is the most common malignant 
endocrine tumor. In a great number of countries, 
this neoplasm is among the ten most common ma-
lignancies. In recent decades, the incidence of thy-
roid cancer (mostly papillary cancer) in the world as 
well as in Croatia has increased dramatically, prob-
ably due to more effi  cient diagnostic tools. Between 
1968 and 2004, the age standardized incidence rate 
of thyroid cancer in Croatia has increased 8.6 times 
in women and 3.6 times in men. Croatia is a country 
with a high incidence but a very low mortality rate 
of thyroid cancer. Th e most recent WHO histopatho-
logic classifi cation of thyroid tumors (updated and 
revised in 2004) distinguishes three major categories 
of thyroid tumors: 1) thyroid cancer (diff erentiated 
thyroid cancer – papillary and follicular; poorly dif-
ferentiated thyroid cancer, medullary and anaplastic); 
2) adenomas and related tumors; and 3) other tumors 
(thyroid lymphomas, metastatic tumors, etc.). Ap-
proximately 90% of thyroid cancers are diff erentiated 
thyroid cancers (mostly papillary) that are fortunately 
less malignant and have excellent prognosis. Detailed 
and exact histologic classifi cation is of utmost impor-
tance not only to the pathologists but also to the clini-
cians because it can lead to better diagnosis and more 
rational therapy. Th e aim of this poster is to indicate 
thyroid cancer incidence and mortality rates in recent 
decades and to show changes in the histopathologic 
features of these cancers during this period in Croa-
tia. Th e aim is also to discuss the probable infl uences 
of the modifi cations in histopathologic classifi cation 
systems, iodine intake, ionizing radiation and other 
factors on thyroid cancer histopathology in Croatia. 
Th e data shown here have been assembled from the 
database of thyroid cancer patients treated at Univer-
sity Department of Oncology and Nuclear Medicine, 
Sestre milosrdnice University Hospital, in close coop-
eration with Ljudevit Jurak University Department of 
Pathology and University Hospital for Tumors.
APOPTOSIS IN CHROMOPHOBE RENAL CELL 
CARCINOMA AND RENAL ONCOCYTOMA
S. Cesarec, A. Demirović, H. Čupić, B. Krušlin,
M. Belicza
Ljudevit Jurak University Department of Pathology, Sestre 
milosrdnice University Hospital, Zagreb, Croatia
Renal oncocytoma is a benign epithelial tumor 
composed of oncocytes, large eosinophilic cells. It ac-
counts for 3%-9% of renal tumors. Chromophobe re-
nal cell carcinoma (ChRCC) is a distinct subtype of 
renal cell carcinoma and comprises approximately 5% 
of all renal tumors. Two main variants are classic and 
eosinophilic ChRCC. Although considered less ag-
gressive than other renal cell carcinomas, ChRCC has 
a metastatic potential. Due to overlapping morpholog-
ical characteristics of renal oncocytoma and ChRCC, 
particularly its eosinophilic variant with the abundant 
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granular eosinophilic cytoplasm, making a correct di-
agnosis can be challenging. Th e aim of this study was to 
assess and compare the apoptotic index, defi ned as the 
absolute number of apoptotic cells per 10 high power 
fi elds (HPFs), in the two tumor groups. Th e fi les from 
Ljudevit Jurak University Department of Pathology, 
Sestre milosrdnice University Hospital were searched 
for cases of histologically confi rmed ChRCCs and 
renal oncocytomas. Slides of 10 ChRCCs and 10 re-
nal oncocytomas, stained by hematoxylin and eosin, 
were analyzed under the light microscope. Apoptotic 
cell was defi ned as a cell with dense, eosinophilic cy-
toplasm and picnotic or defragmented nucleus. Th e 
absolute number of apoptotic cells per 10 HPFs in the 
two tumor groups was counted. In the group of renal 
oncocytomas there were a mean of 7.8% apoptotic cells 
per 10 HPFs (range 4-12). In the group of ChRCCs 
there were 2.5% apoptotic cells per 10 HPFs (range 
1-6). Apoptosis is the process of programmed cell 
death. Dysregulation of apoptosis is a key process in 
cancer development and progression. Th e aim of this 
study was to assess and compare the apoptotic index in 
the two tumor groups. Although there was visible dif-
ference in the mean number of apoptotic cells between 
the two tumor groups, this study was partially limited 
by the modest number of cases and further studies are 
needed to explore the possible use of apoptotic index 
assessment in the diff erential diagnosis between renal 
oncocytoma and ChRCC.
SCROTAL DIROFILARIASIS IN A 3-YEAR-OLD 
CHILD
Z. Marušić1, B. Pigac2, S. Radiković2, A. Kopljar2,
D. Tomas1, B. Krušlin1
1Ljudevit Jurak University Department of Pathology, Sestre 
milosrdnice University Hospital, Zagreb; 2Department of 
Pathology, Varaždin General Hospital, Varaždin, Croatia
Dirofilariasis is an uncommon zoonosis caused 
by parasites of the genus Dirofilaria, most notably D. 
repens and D. immitis in Europe. Canines represent 
the reservoir of infection, 
while human infections are sporadic. Th e infec-
tion is transmitted by the bite of a mosquito carrying 
parasitic larvae. We report a case of a 3-year-old boy 
with a scrotal nodule measuring up to 1 cm in diam-
eter. Upon excision of the nodule, the surgeon noticed 
a thread-like parasite exiting the incision site, which 
he submitted separately from the nodule. Microscopic 
examination of the excision specimen revealed a canal 
of granulation tissue located in deep dermis, which did 
not extend to the excision margin. Microscopic exam-
ination of the thread-like material disclosed a parasite 
whose morphology was well-preserved in some of the 
sections. It was composed of a thick cuticle with lon-
gitudinal ridges (micro-ruffling of the surface), large 
lateral chords, tall, slender coelomian muscle layer, 
a single gut tube and spermatocytes in the genital 
tubule. Th e morphology of the parasite was consis-
tent with a helminth from the genus Dirofi laria. In 
humans, dirofi lariasis most often manifests as a sub-
cutaneous nodule or less frequently as the so-called 
“coin lesion” in the lung comprising of microfilarial 
emboli in a branch of pulmonary artery. In Croatia, 
there have been approximately a dozen case reports of 
dirofi larial infection in humans. Most of the cases re-
ported were from the Mediterranean part of Croatia, 
which may represent an endemic area of dirofilariasis. 
Th e diagnosis of subcutaneous dirofilariasis should be 
considered in the diff erential diagnosis of a subcutane-
ous helminthic infection. Physicians should be aware 
of this disease and its features for several reasons, 
primarily in order not to mistake coin lesions in the 
lung for malignancy and not to mistake dirofilarias in 
subcutaneous nodules for other, more harmful tropi-
cal parasites such as Wuchereria bancrofti or Onchocerca 
volvulus. In subcutaneous nodules, PCR analysis is an 
elegant way to overcome diagnostic obstacles caused 
by altered morphology and/or lack of familiarity with 
the specific morphology of filarial species. Surgical 
treatment of subcutaneous dirofilariasis in humans is 
considered curative and there is no need for further 
interventions besides clinical monitoring.
HISTOLOGIC SUBTYPES OF INVASIVE 
LOBULAR CARCINOMA IN CORRELATION WITH 
TUMOUR STATUS AND HORMONE RECEPTORS
I. Miše1,  M. Vučić2,  I. Maričević1, M. Šokčević1,
C. Lež3, S. Čurić-Jurić1
1Cytology Division, University Department of Medicine, 
2Ljudevit Jurak University Department of Pathology, Sestre 
milosrdnice University Hospital, Zagreb, Croatia
3General Hospital Zabok, Zabok, Croatia
Invasive lobular carcinoma is a distinct biological 
entity with several histologic variants the prognostic 
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value of which has not yet been fully elucidated. Th e 
aim of this study was to determine the immunohis-
tochemical expression of estrogen receptors (ER) and 
progesterone receptors (PR) in the subtypes of lobu-
lar breast carcinoma (classic and variant types) and to 
correlate them with clinical and tumor parameters. 
Fifty lobular carcinomas, 33 classic and 17 variant, 
were analyzed. Th e classic type was more frequent 
(66%) in older women (age 61) and smaller in size 
(1.5 cm), with N0 status and modestly positive ER 
and PR. Variant types were more frequent in younger 
women (age 55), larger in size (2.5 cm), with N1 sta-
tus and maximal positive ER and PR. ER was ex-
pressed in 82% and PR in 78% of tumors, mostly with 
maximal expression without diff erences in the inten-
sity among the subtypes. Only one tumor of classic 
type was HER/2neu 3+, ER and PR-. ER expression 
was signifi cantly associated with a lower incidence of 
other proliferative lesions (P=0.043). Th e total sample 
and classic type were characterized by a signifi cant 
positive correlation between ER and PR (P=0.004) 
and between tumor size and N status (P=0.005), and 
negative correlation between HER/2neu and N status 
(P=0.042). In variant types, larger tumors were relat-
ed to higher N (P=0.021) and higher ER expression 
was associated with smaller tumors (P=0.044). Th e 
study indicated distinct biological features of lobular 
carcinoma subtypes and pointed to the need of a more 
selective therapeutic approach.
STRUMAL CARCINOID OF THE OVARY: A 
REPORT OF TWO CASES
T. Leniček1, D. Tomas1,3, H. Soljačić-Vraneš2,
Z. Kraljević2, P. Klarić2, M. Kos1,3
1Ljudevit Jurak University Department of Pathology, 
2University Department of Gynecology and Obstetrics, 
Sestre milosrdnice University Hospital; 3School of 
Medicine, University of Zagreb, Zagreb, Croatia
Strumal carcinoid is an unusual form of ovarian 
teratoma composed of an intimate admixture of thyroid 
and carcinoid tissues that vary in their relative propor-
tions. We describe two patients with primary ovarian 
strumal carcinoid. Case 1: a 40-year-old woman was 
admitted to the hospital with a 4-year clinical history 
of myoma uteri and no symptoms, except for consti-
pation persisting for several months. At laparotomy, a 
smooth, hard, solid tumor originating in the left ovary, 
measuring 9 cm in largest diameter, was found. Case 
2: a 44-year-old asymptomatic woman was admitted 
to the hospital for a clinical fi nding of the left ovarian 
cyst. At laparoscopy, a multicystic left ovarian tumor 
with a smooth outer surface, measuring up to 9 cm in 
largest diameter, was found. Histopathologically, both 
tumors were composed of an admixture of carcinoid 
tumor and normal thyroid tissue. A trabecular variant 
of carcinoid was found in case 1 and insular variant of 
carcinoid in case 2. Immunohistochemically, the car-
cinoid cells were diff usely positive for synaptophysin 
and neuron specifi c enolase (NSE) and focally posi-
tive for chromogranin A. Th yroid tissue with typical 
thyroid follicles was immunohistochemically positive 
for thyroglobulin and TTF. Strumal carcinoid was 
defi nitive diagnosis in both cases. Primary ovarian 
carcinoid tumors are uncommon and account for less 
than 0.1% of ovarian malignancies. Secondary or met-
astatic carcinoids from the gastrointestinal tract in the 
ovary are four times less common than primary carci-
noids. Patients with primary ovarian carcinoids show 
symptoms of an abdominal mass, or the tumor is an 
incidental fi nding. Some patients show signs of carci-
noid syndrome (episodic cutaneous fl ushing, cyanosis, 
abdominal cramps, diarrhea, carcinoid heart disease, 
etc.), mediated by bioactive polypeptides produced by 
carcinoid tumor cells. Microscopically, there are four 
major variants of ovarian teratomas of carcinoid type: 
insular, trabecular, strumal and mucinous. Carcinoid 
syndrome is a very rare manifestation of strumal car-
cinoid. Even though carcinoids can typically cause the 
carcinoid syndrome, with diarrhea as one of the symp-
toms, several cases of strumal carcinoid were reported 
in patients exhibiting severe constipation, induced by 
the gut hormone, peptide YY that has a strong in-
hibitory eff ect on intestinal motility. Th e fi rst patient 
we describe also suff ered from constipation that was 
relieved after the surgery. Strumal carcinoid can also 
be responsible for carcinoid heart disease. Th e patients 
presented had ovarian tumors showing typical mor-
phology of ovarian strumal carcinoids. Clinical follow 
up of the patients is only two years in case 1 and six 
months in case 2, and the patients have no signs of 
recurrence or distant spread of the tumor.
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MULTIPLE METASTASES OF RENAL CELL 
CARCINOMA TO THE THYROID GLAND:
CASE REPORT
L. Labinac-Peteh1, T. Leniček2, I. Kučinar1, H. Čupić2
1Department of Pathology and Forensic Medicine, 
Pula General Hospital, Pula; 2Ljudevit Jurak University 
Department of Pathology, Sestre milosrdnice University 
Hospital, Zagreb, Croatia
We present a rare case of multiple metastases of 
clear cell renal cell carcinoma (RCC) presenting as 
thyroid tumor 4 years after nephrectomy. Th e patient, 
a 75-year-old woman, was referred to Pula General 
Hospital for total thyroidectomy because of a giant, 
euthyroid, retrosternal struma, with the symptoms of 
tracheal compression. All laboratory fi ndings includ-
ing thyroid hormone status were within the normal 
limits. On gross examination, the thyroid gland was 
enlarged, with few well circumscribed, whitish nodes 
on the cut surface. On microscopic analysis, well con-
fi ned solid and alveolar clusters of atypical epithelial 
cells were found in the thyroid gland. A distinct fea-
ture of tumor cells was their clear cytoplasm and a 
hyperchromatic nucleus. On immunohistochemical 
examination, tumor cells showed positive reaction for 
CD 10, EMA and vimentin. Th e reaction for TTF-1 
was negative. According to history data, histologic 
examination and immunohistochemical analysis, the 
case was signed out as RCC metastases to the thyroid 
gland. One month after the operation, there were no 
signs of metastatic disease on postoperative computer 
tomography of the head and thorax and on abdominal 
ultrasound examination. All laboratory fi ndings were 
within the normal limits.
ADRENAL MYELOLIPOMA
P. Sesar, I. Pavić, M. Ulamec, B. Krušlin
1Department of Pathology, Sisak General Hospital, Sisak; 
2Ljudevit Jurak University Department of Pathology, Sestre 
milosrdnice University Hospital, Zagreb, Croatia
Adrenal gland myelolipoma (ML) is a rare dis-
ease. Most lesions are discovered incidentally at au-
topsy or imaging studies performed for other reasons. 
Diff erential diagnosis of the suprarenal mass depends 
on preoperative imaging and biopsy. We performed 
a ten-year retrospective cross sectional study of 11 
MLs. Diagnosis was established by the set of typi-
cal histologic fi ndings on standard hematoxylin-eosin 
staining. In all 11 cases, ML was incidentally found 
by computer tomography (CT) scan. Seven MLs were 
found in six men (one man had bilateral adrenal ML) 
and four in women. Th e diameter of adrenal tumor 
mass ranged from 0.5 to up to 13.9 cm. Macroscopic 
examination revealed an oval encapsulated yellowish 
soft tumor located in the adrenal gland, with a thin 
rim of macroscopically normal adrenal tissue. Histo-
logic examination showed proliferation of adipocytes 
which were dissociated from several hemorrhagic foci 
and myeloid tissue that contained megakaryocytes, 
erythroid cells and lymphocytes. Th e surface of the 
tumor mass was covered with a fi brous capsule. On 
the periphery there was normal adrenal tissue with 
no signifi cant changes. Since fi rst described in 1905 
by Girke, MLs are arising out as a rare, probably be-
nign adrenal neoplasm. Most of the lesions are small 
and asymptomatic, incidentally discovered on clini-
cal and CT scan examination, with the size varying 
from several millimeters to more than 30 cm. Th e 
most common complications develop due to pressure 
upon the neighboring organs. Diff erential diagnosis 
of a suprarenal fatty mass includes myelolipoma, renal 
angiomyolipoma extending from the upper pole, and 
retroperitoneal lipoma and liposarcoma.
EFFECTIVENESS OF TRANSSPHENOIDAL 
SURGERY AS AN INITIAL TREATMENT FOR 
NON-FUNCTIONING PITUITARY ADENOMAS – 
PERSONAL EXPERIENCE IN CLINICAL PRACTICE 
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Th e vast majority (>80%) of clinically non-func-
tioning pituitary adenomas (NFPAs) are gonadotro-
ph-cell adenomas, as demonstrated by immunocy-
tochemistry. However, they are rarely associated with 
increased levels of dimeric LH or FSH and usually 
clinically presented by tumor mass eff ect, and there-
fore need to be distinguished from asymptomatic in-
cidentalomas. Th e aim of this study was to defi ne the 
impact of surgery on regression of tumor compression 
symptoms in a series of patients with NFPAs under-
going endoscopic transsphenoidal surgery (TSS) dur-
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ing the 2008-2009 period at our Department, which 
is the Reference Center for Hypothalamus-Pituitary 
Diseases in Croatia. A total of 31 patients underwent 
TSS, 11 (35.5%) of them female. Th e male and female 
patients were aged 17-84 and 62-76 years, respective-
ly. Twenty-eight (90%) patients had macroadenoma, 
which was the predominant type of NFA both in men 
(n=19; 95%) and women (n=9; 82%). After surgery, 
visual fi eld defects remained in 10 cases. Postopera-
tively, three (9.7%) patients had hypogonadism, 15 
(48%) adrenal insuffi  ciency, one (3.2%) patient hy-
pothyroidism and two (6.5%) patients panhypopitu-
itarism; all of which initially were macroadenomas. 
Two (6.5%) out of six (19.3%) MRI detected residual 
masses were successfully reoperated. Postoperatively, 
the three patients operated on for microadenomas 
had no residual masses on MRI and no need for hor-
mone replacement therapy or additional treatment. 
In conclusion, considering that the results of medi-
cal treatment with dopamine agonists and somatosta-
tin analogues are disappointing, TSS is the primary 
therapeutic approach in resolving symptomatic NFAs, 
especially microadenomas. Th e strategy of observa-
tion for patients with incidentally discovered pituitary 
adenomas is appropriate, provided that the tumor is 
well-delimited, small, has no extension with the risk 
of neurologic or visual chiasm compression, and that a 
meticulous hormonal work-up has ruled out the pos-
sibility of minimal hormonal hypersecretion.
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Department of Endocrinology, Diabetes and Metabolism, 
Sestre milosrdnice University Hospital, Zagreb, Croatia
Department of Endocrinology, Diabetes and Me-
tabolism, Sestre milosrdnice University Hospital is 
reference center for hypothalamus-pituitary diseases 
in Croatia. Acromegaly is a rare chronic debilitating 
disorder mainly caused by a growth hormone (GH)-
producing pituitary adenoma. Acromegaly is asso-
ciated with a two- to fourfold increase in mortality 
risk, mainly from cardiovascular disease, unless serum 
growth hormone (GH) levels are below 2 microg/L 
and serum insulin-like growth factor (IGF)-I levels are 
normal following medical treatment. Th ese combined 
criteria were used to defi ne remission of the disorder 
in this study. Th e aim of this retrospective analysis 
was to evaluate, using the biochemical parameter of 
remission, the initial outcome in a series of acromegaly 
patients operated by endoscopic transsphenoidal pitu-
itary surgery (TSS). A total of 21 consecutive patients, 
12 (57%) of them female, underwent surgery in 2008-
2009. Th e male and female patients were aged 25-70 
and 27-74 years, respectively. Twelve (57%) patients 
had macroadenoma, which was the predominant type 
of pituitary tumor in men (66%). In women, the num-
ber of micro- and macroadenomas was equal (n=6). 
None of the patients had ever been treated before. 
Hormonal assessment was performed at 6 months of 
surgery. Fifteen (71.4%) patients achieved biochemi-
cal remission of acromegaly. Th e remission rate at 6 
months was 100% in patients with microadenoma and 
50% in those with macroadenoma. Th e combined use 
of TSS and treatment with somatostatin analogues 
was benefi cial for another three (14 %) patients, and 
two more (9.5%) achieved optimal control of tumor 
growth and endocrinological normalization by apply-
ing gamma knife radiosurgery (GKRS). In one (4.7%) 
patient, there was no favorable clinical result despite 
optimal combined therapy. In conclusion, TSS is ben-
efi cial and considered as the treatment of choice in 
the hands of experienced neurosurgeon because for 
providing rapid cure and normalization of survival in 
most cases. However, in some patients optimal control 
of tumor growth and normalization of hypersecretory 
states are achieved by secondary treatment modalities, 
including GKRS and somatostatin analogues.
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Prolactinomas are the most common hormone-
secreting pituitary tumors. Medical therapy with 
dopaminergic agonists (DA) is the preferred initial 
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treatment for symptomatic prolactin (PRL)-secret-
ing adenomas. However, in recent years, there has 
been a renewed interest in surgery. Th e aim of this 
retrospective analysis is to report a series of patients 
operated for prolactinoma in 2008-2009 at our De-
partment, which is the reference center for hypothal-
amus-pituitary diseases in Croatia. All patients were 
diagnosed on the basis of neuroradiological imaging 
and endocrine assessment of pituitary function. A to-
tal of 61 consecutive patients underwent endoscopic 
transsphenoidal pituitary surgery (TSS), 46 (75.4%) 
of them female. Th e male and female patients were 
aged 20-67 and 19-70 years, respectively. Twenty-two 
(36.0%) patients had macroadenoma, which was the 
predominant type of prolactinoma in men (73.3%). In 
women, microadenomas were more common (n=35; 
76.0%). None of the patients had ever been treated 
before. After surgery, normalization of PRL levels 
occurred in 55 (90.2%) patients. Complete remission 
was achieved in all microadenoma cases. Six (9.8 %) 
patients with postoperatively high PRL levels initially 
had macroadenomas, and were in sequence treated 
with DA. Four patients resistant to DA and TSS 
underwent gamma knife radiosurgery (GKRS) with 
subsequent endocrinological normalization of PRL in 
two additional patients. Th e two remaining patients 
with incomplete remission had follow-up duration of 
one year that may have underestimated the complete 
response rate for tumors treated with GKRS. In sum-
mary, initial TSS therapy normalized PRL levels and 
relieved symptoms of hyperprolactinemia in a signifi -
cant majority of patients, whereas morbidity of TSS 
is low in the hands of experienced pituitary surgeons. 
TSS can be off ered as a defi nitive therapy, especially 
to patients with microadenomas.
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Th e clinical and pathologic features of alveolar 
rhabdomyosarcoma of the left ankle joint in a 73-
year-old woman are presented. Th e patient presented 
to surgery clinic because of redness and edema in the 
foot area (she mentioned a possible insect sting), and 
edema of her left leg. Urgent CD test of arteries and 
left leg veins was done and vascular events were ex-
cluded. On ultrasonography scan, a hypoechoic lesion 
of solid appearance was subcutaneously verifi ed in the 
area of the left ankle lateral malleolus. Computed to-
mography (CT) scan of the pelvis confi rmed the test 
results, showing enlarged lymph nodes of up to 30 
mm in diameter parailiacally on the left and in the left 
inguinal region. Biopsy of the solid formation in the 
area of the lateral ankle was obtained, later followed 
by needle biopsy of the left inguinal lymph nodes. 
Histopathologic analysis of the solid tumor showed 
tumor tissue composed of fi brous septa covered with 
small to polygonal, mitotically active atypical tumor 
cells, and of hyperchromatic nuclei of solid and al-
veolar growth. Tumor cell mimunohistochemistry 
showed positive reaction for desmin, vimentin and 
myoglobin. Histology and immunohistochemistry 
(desmin, myoglobin, vimentin, CK-PAN, S-100 pro-
tein, synaptophysin, CD31) corresponded to alveolar 
rhabdomyosarcoma. Needle biopsy of lymph nodes 
was indicative of a malignant tumor of undiferenti-
ated round cells. Th e patient died two months of the 
surgery. Alveolar rhabdomyosarcoma of foot is a rare 
cause of lymphedema of foot in adults. Alveolar rhab-
domyosarcoma is a primitive, malignant, round-cell 
neoplasm that cytologically resembles lymphoma 
and shows partial skeletal muscle diff erentiation. Th e 
prognosis of alveolar rhabdomyosarcoma is distinctly 
worse than for the embryonal variety, even with the 
most recent combined treatment modalities.
